MustGrow Biologics (MGROF) Financial Statements
MustGrow Biologics Financial Overview
MustGrow Biologics's market cap is currently $18.15M. The company's EPS TTM is $-0.09; its P/E ratio is -3.71; MustGrow Biologics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 8.29M | $ 398.02K | $ 4.71M | $ 6.48K | $ 12.87K |
| Gross Profit | $ 1.41M | $ 300.75K | $ 4.33M | $ 6.48K | $ 12.87K |
| Operating Income | $ -6.25M | $ -5.11M | $ -804.99K | $ -5.56M | $ -3.01M |
| EBITDA | $ -6.20M | $ -4.89M | $ -676.94K | $ -5.56M | $ -3.01M |
| Net Income | $ -7.26M | $ -4.89M | $ -676.94K | $ -5.57M | $ -3.06M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 918.77K | $ 3.00M | $ 6.82M | $ 7.02M | $ 9.62M |
| Total Assets | $ 3.09M | $ 5.42M | $ 6.94M | $ 7.13M | $ 9.70M |
| Total Debt | $ 584.13K | $ 517.99K | $ 759.33K | $ 759.33K | $ 749.27K |
| Net Debt | $ -334.63K | $ -2.48M | $ -6.06M | $ -6.26M | $ -8.87M |
| Total Liabilities | $ 2.23M | $ 3.25M | $ 1.35M | $ 1.90M | $ 1.25M |
| Stockholders' Equity | $ 867.10K | $ 2.17M | $ 5.58M | $ 5.24M | $ 8.46M |
| Cash Flow | |||||
| Free Cash Flow | $ -6.56M | $ -3.58M | $ -294.76K | $ -3.26M | $ -2.41M |
| Operating Cash Flow | $ -5.06M | $ -3.58M | $ -294.76K | $ -3.26M | $ -2.41M |
| Investing Cash Flow | $ -1.50M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 4.48M | $ -241.34K | $ 95.75K | $ 653.75K | $ 8.72M |
Currency in CAD